CAS: 1228690-19-4
![[1,1'-Biphenyl]-4-acetic acid, 4'-[4-[[[(1R)-1-(2-chlorophenyl)ethoxy]carbonyl]amino]-3-methyl-5-i…](https://static.cymitquimica.com/products/IN/thumb/DA000JNN.jpg)
[1,1'-Biphenyl]-4-acetic acid, 4'-[4-[[[(1R)-1-(2-chlorophenyl)ethoxy]carbonyl]amino]-3-methyl-5-isoxazolyl]-
CAS:1228690-19-4
Formula:
C27H23ClN2O5
Purity:
98%
Color and Shape:
Solid
Molecular weight:
490.9349
Ref: IN-DA000JNN
| 1g | To inquire | ||
| 5mg | 67.00 € | ||
| 50mg | 169.00 € | ||
| 100mg | 254.00 € | ||
| 250mg | 571.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
AM966
CAS:1228690-19-4
AM966, a excellent affinity, specific, oral LPA1(IC50=17 nM) antagonist, suppresses LPA-stimulated intracellular calcium release.
Formula:
C27H23ClN2O5
Purity:
97.32% - 99.49%
Color and Shape:
Solid
Molecular weight:
490.93
Ref: TM-T4278
| 5mg | 38.00 € | ||
| 10mg | 56.00 € | ||
| 25mg | 93.00 € | ||
| 50mg | 159.00 € | ||
| 100mg | 246.00 € | ||
| 200mg | 354.00 € | ||
| 1mL*10mM (DMSO) | 42.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
![(R)-2-(4'-(4-(((1-(2-Chlorophenyl)ethoxy)carbonyl)amino)-3-methylisoxazol-5-yl)-[1,1'-biphenyl]-4-…](https://static.cymitquimica.com/products/3D/thumb/DZB69019.jpg)
(R)-2-(4'-(4-(((1-(2-Chlorophenyl)ethoxy)carbonyl)amino)-3-methylisoxazol-5-yl)-[1,1'-biphenyl]-4-yl)acetic acid
CAS:1228690-19-4
Please enquire for more information about (R)-2-(4'-(4-(((1-(2-Chlorophenyl)ethoxy)carbonyl)amino)-3-methylisoxazol-5-yl)-[1,1'-biphenyl]-4-yl)acetic acid including the price, delivery time and more …
Formula:
C27H23ClN2O5
Purity:
Min. 95%
Molecular weight:
490.94 g/mol
Ref: 3D-DZB69019
| 1mg | Discontinued | Request information | |
| 2mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information |
